Literature DB >> 23400347

Exploring the manifestations of anxiety in children with autism spectrum disorders.

Victoria Hallett1, Luc Lecavalier, Denis G Sukhodolsky, Noreen Cipriano, Michael G Aman, James T McCracken, Christopher J McDougle, Elaine Tierney, Bryan H King, Eric Hollander, Linmarie Sikich, Joel Bregman, Evdokia Anagnostou, Craig Donnelly, Lily Katsovich, Kimberly Dukes, Benedetto Vitiello, Kenneth Gadow, Lawrence Scahill.   

Abstract

This study explores the manifestation and measurement of anxiety symptoms in 415 children with ASDs on a 20-item, parent-rated, DSM-IV referenced anxiety scale. In both high and low-functioning children (IQ above vs. below 70), commonly endorsed items assessed restlessness, tension and sleep difficulties. Items requiring verbal expression of worry by the child were rarely endorsed. Higher anxiety was associated with functional language, IQ above 70 and higher scores on several other behavioral measures. Four underlying factors emerged: Generalized Anxiety, Separation Anxiety, Social Anxiety and Over-arousal. Our findings extend our understanding of anxiety across IQ in ASD and provide guidance for improving anxiety outcome measurement.

Entities:  

Mesh:

Year:  2013        PMID: 23400347      PMCID: PMC4038127          DOI: 10.1007/s10803-013-1775-1

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  25 in total

1.  Factor validity and norms for the aberrant behavior checklist in a community sample of children with mental retardation.

Authors:  E C Marshburn; M G Aman
Journal:  J Autism Dev Disord       Date:  1992-09

2.  Further evidence of reliability and validity of the Child Symptom Inventory-4: parent checklist in clinically referred boys.

Authors:  Joyce Sprafkin; Kenneth D Gadow; Helen Salisbury; Jayne Schneider; Jan Loney
Journal:  J Clin Child Adolesc Psychol       Date:  2002-12

3.  Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity.

Authors:  L Scahill; M A Riddle; M McSwiggin-Hardin; S I Ort; R A King; W K Goodman; D Cicchetti; J F Leckman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-06       Impact factor: 8.829

4.  The presentation of anxiety in children with pervasive developmental disorders.

Authors:  Deborah M Weisbrot; Kenneth D Gadow; Carla J DeVincent; John Pomeroy
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-06       Impact factor: 2.576

5.  Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders.

Authors:  Lawrence Scahill; James T McCracken; Karen Bearss; Fay Robinson; Eric Hollander; Bryan King; Joel Bregman; Lin Sikich; Kimberly Dukes; Lisa Sullivan; Evdokia Anagnostou; Craig Donnelly; Young-Shin Kim; Louise Ritz; Deborah Hirtz; Ann Wagner
Journal:  J Autism Dev Disord       Date:  2012-03

6.  Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.

Authors:  Christopher J McDougle; Lawrence Scahill; Michael G Aman; James T McCracken; Elaine Tierney; Mark Davies; L Eugene Arnold; David J Posey; Andrès Martin; Jaswinder K Ghuman; Bhavik Shah; Shirley Z Chuang; Naomi B Swiezy; Nilda M Gonzalez; Jill Hollway; Kathleen Koenig; James J McGough; Louise Ritz; Benedetto Vitiello
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

7.  Factor analysis and norms for parent ratings on the Aberrant Behavior Checklist-Community for young people in special education.

Authors:  Elaine C Brown; Michael G Aman; Susan M Havercamp
Journal:  Res Dev Disabil       Date:  2002 Jan-Feb

8.  The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

Authors:  M G Aman; N N Singh; A W Stewart; C J Field
Journal:  Am J Ment Defic       Date:  1985-03

9.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; R L Fleischmann; C L Hill; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11

10.  Risperidone in children with autism and serious behavioral problems.

Authors:  James T McCracken; James McGough; Bhavik Shah; Pegeen Cronin; Daniel Hong; Michael G Aman; L Eugene Arnold; Ronald Lindsay; Patricia Nash; Jill Hollway; Christopher J McDougle; David Posey; Naomi Swiezy; Arlene Kohn; Lawrence Scahill; Andres Martin; Kathleen Koenig; Fred Volkmar; Deirdre Carroll; Allison Lancor; Elaine Tierney; Jaswinder Ghuman; Nilda M Gonzalez; Marco Grados; Benedetto Vitiello; Louise Ritz; Mark Davies; James Robinson; Don McMahon
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

View more
  54 in total

1.  An exploration of concomitant psychiatric disorders in children with autism spectrum disorder.

Authors:  Luc Lecavalier; Courtney E McCracken; Michael G Aman; Christopher J McDougle; James T McCracken; Elaine Tierney; Tristram Smith; Cynthia Johnson; Bryan King; Benjamin Handen; Naomi B Swiezy; L Eugene Arnold; Karen Bearss; Benedetto Vitiello; Lawrence Scahill
Journal:  Compr Psychiatry       Date:  2018-11-06       Impact factor: 3.735

2.  Psychometric Properties of the Spence Children's Anxiety Scale: Parent Report in Children with Autism Spectrum Disorder.

Authors:  Katia Jitlina; Bruno Zumbo; Pat Mirenda; Laurie Ford; Teresa Bennett; Stelios Georgiades; Charlotte Waddell; Isabel M Smith; Joanne Volden; Eric Duku; Lonnie Zwaigenbaum; Peter Szatmari; Tracy Vaillancourt; Mayada Elsabbagh
Journal:  J Autism Dev Disord       Date:  2017-12

Review 3.  Anxiety Disorders and Obsessive-Compulsive Disorder in Individuals with Autism Spectrum Disorder.

Authors:  Valentina Postorino; Connor M Kerns; Giacomo Vivanti; Jessica Bradshaw; Martina Siracusano; Luigi Mazzone
Journal:  Curr Psychiatry Rep       Date:  2017-10-30       Impact factor: 5.285

4.  Clinical Correlates of Co-occurring Psychiatric and Autism Spectrum Disorder (ASD) Symptom-Induced Impairment in Children with ASD.

Authors:  Kenneth D Gadow; Greg Perlman; Lianne Ramdhany; Janneke de Ruiter
Journal:  J Abnorm Child Psychol       Date:  2016-01

5.  Sensory Over-Responsivity: An Early Risk Factor for Anxiety and Behavioral Challenges in Young Children.

Authors:  Kimberly L H Carpenter; Grace T Baranek; William E Copeland; Scott Compton; Nancy Zucker; Geraldine Dawson; Helen L Egger
Journal:  J Abnorm Child Psychol       Date:  2019-06

6.  Reliability and validity of parent- and child-rated anxiety measures in autism spectrum disorder.

Authors:  Aaron J Kaat; Luc Lecavalier
Journal:  J Autism Dev Disord       Date:  2015-10

7.  Brief measures of anxiety in non-treatment-seeking youth with autism spectrum disorder.

Authors:  Connor Morrow Kerns; Brenna B Maddox; Philip C Kendall; Keiran Rump; Leandra Berry; Robert T Schultz; Margaret C Souders; Amanda Bennett; John Herrington; Judith Miller
Journal:  Autism       Date:  2015-01-29

8.  Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder.

Authors:  Lawrence Scahill; Karen Bearss; Rena Sarhangian; Christopher J McDougle; L Eugene Arnold; Michael G Aman; James T McCracken; Elaine Tierney; Scott Gillespie; Valentina Postorino; Benedetto Vitiello
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-11-28       Impact factor: 2.576

9.  A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures.

Authors:  Laura C Politte; Lawrence Scahill; Janet Figueroa; James T McCracken; Bryan King; Christopher J McDougle
Journal:  Neuropsychopharmacology       Date:  2018-02-27       Impact factor: 7.853

10.  A preliminary investigation of the Spence Children's Anxiety Parent Scale as a screening tool for anxiety in young people with autism spectrum disorders.

Authors:  Hani Zainal; Iliana Magiati; Julianne Wen-Li Tan; Min Sung; Daniel S S Fung; Patricia Howlin
Journal:  J Autism Dev Disord       Date:  2014-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.